Prostate cancer screening was revolutionized in the early 1990s with the wide spread availability and FDA approval of PSA testing. PSA however is not specific for clinically significant prostate ...

Indications for and implications of germline genetic testing (GGT) in patients with prostate cancer have expanded over the past decade, particularly related to precision therapies and management. GGT ...

MRI-guided transurethral ultrasound ablation associated with less blood loss, shorter stays, and less pain than robotic prostatectomy.

AI is becoming crucial in prostate cancer care, improving diagnosis and treatment stratification through enhanced imaging and risk assessment. AI-generated cancer mapping has shown superior accuracy ...

• Applications of germline genetic testing, tumor genomics, and other biomarkers are now routinely used in risk assessment, determination of treatment course, prognosis, and monitoring. • Imaging ...

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

Multidisciplinary care in prostate cancer involves urologic, radiation, and medical oncologists, optimizing treatment through a collaborative approach. Clinical trials may benefit patients with ...

Türkiye: A recent randomized controlled study published in Seminars in Oncology Nursing by Gamze Bozkul from the Faculty of ...

CHICAGO — Prostate-specific antigen (PSA) levels could help guide treatment decisions for patients with metastatic hormone-sensitive prostate cancer, according to real-world findings from the IRONMAN ...

The IAEA is launching a year-long coordinated research project to develop computed tomography-based guidelines on prostate cancer contouring — a critical step in the cancer treatment process that ...